IMMUNOLOGICAL ANALYSIS OF PATIENTS WITH MALIGNANT TUMORS OF THE PAROTID GLAND


Cite item

Full Text

Abstract

Malignant tumors of the parotid glands are less common than benign, but on 3–4 stages of the disease, when one can only talk about life extension. Identification of biomarkers is important not only for the possibility of early diagnostics of malignant tumors of the parotid, but also for long-term observations.

About the authors

E. V Kochurova

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

S. V Kozlov

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

V. N Nikolenko

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

V. S Anis’kina

V.G. Korolenko municipal clinical hospital № 14

107076, Moscow, Russian Federation

A. L Karpashevich

V.G. Korolenko municipal clinical hospital № 14

107076, Moscow, Russian Federation

M. V Skripnichenko

V.G. Korolenko municipal clinical hospital № 14

107076, Moscow, Russian Federation

I. G Asinovskov

V.G. Korolenko municipal clinical hospital № 14

107076, Moscow, Russian Federation

O. S Gujter

I.M. Sechenov First Moscow State Medical University

119991, Moscow, Russian Federation

References

  1. Ho K., Lin H., Ann D.K., Chu P.G. et al. An overview of the rare parotid gland cancer. Head Neck Oncol. 2011; 14; 3: 40.
  2. Horner M.J., Ries L.A.G., Krapcho M., eds. SEER cancer statistics review, 1975–2006. Bethesda, MD: National Cancer Institute; 2009.
  3. Rubin R., Strayer D.S., eds. Rubin’s pathology: Clinicopathologic foundations of medicine. 4 th ed. Maryland: Lippincott Williams & Wilkins; 2004: 1283–5.
  4. Nagler R.M., Laufer D. Tumors of the major and minor salivary glands: review of 25 years of experience. Anticancer Res. 1997; 17: 701–7.
  5. Pinkston J.A., Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol. Head Neck Surg. 1999; 120: 834–40.
  6. Davidson T.M. Clinical manual of otolaryngology. 3-rd ed. University of California Medical School, San Diego, California, Copyright 2006 Regents University of California. Formerly published under the title Clinical Manual of Otolaryngology, McGraw-Hill Inc; 1992.
  7. Salivary gland cancer overview. Learn about cancer from the American Cancer Society. 2012. Copyright.
  8. Azuma M., Kasai Y., Tamatani T. et al. Involvement of p53 mutation in the development of human salivary gland pleomorphic adenomas. Cancer Lett. 1992; 65(1): 61–71.
  9. Streckfus C., Bigler L., Tucci M. et al. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 2000; 18(2): 101–9.
  10. Corstjens PLAMMD. Point-of-care diagnostics for infectious diseases. In: Wong D.T., ed. Saliva diagnostics. Ames: Wiley-Blackwell; 2008: 243–54.
  11. Farnaud S.J., Kosti O., Getting S.J. et al. Saliva: physiology and diagnostic potential in health and disease. Scient. World J. 2010; 10: 434–56.
  12. Streckfus C., Bigler L. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv. Dent. Res. 2005; 18(1): 17–24.
  13. Malamud D., Niedbala R.S. Oral-based diagnostics. Boston Mass.: New York Academy of Sciences. Published by Blackwell Pub. on behalf of the New York Academy of Sciences; 2007.
  14. Santos M.T., Batista R. et al. Salivary osmolality and hydration status in children with cerebral palsy. J. Oral Pathol. Med. 2011; 40(7): 582–6.
  15. Козлов С.В., Кочурова Е.В. Биомаркеры ротовой жидкости в диагностике пациентов с раком челюстно-лицевой области. В кн.: X Всероссийская научно-практическая конференция “Образование, наука и практика в стоматологии”. М.; 2013: 120.

Copyright (c) 2013 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies